Table 1.
Tumor type | P16 IHC (%) | HPV ISH (%) |
---|---|---|
Small cell carcinoma | 3/3 (100) | 0/3 (0) |
Non-small cell carcinoma, NOS | 1/12 (8) | 0/12 (0) |
Adenocarcinoma | 15/74 (20) | 0/74 (0) |
Large cell/pleomorphic carcinoma | 4/11 (36) | 0/11 (0) |
Squamous cell carcinoma | ||
No prior squamous cell carcinoma | 14/66 (21) | 0/66 (0) |
Prior head and neck squamous cell carcinoma* | 17/54 (31) | 11/54 (20) |
oropharynx | 15/28 (54) | 11/28 (39) |
oral cavity | 1/7 (14) | 0/7 (0) |
larynx | 1/20 (5) | 0/20 (0) |
hypopharynx | 0/1 (0) | 0/1 (0) |
IHC, immunohistochemistry; HPV, human papillomavirus; ISH, in situ hybridization; NOS, not otherwise specified
two patients had primary SqCCs involving the oropharynx and a non-oropharyngeal site